RCT: Posaconazole noninferior to voriconazole for primary treatment of invasive aspergillosis

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)